Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 79

1.

Anti-p200 pemphigoid is the most common pemphigoid disease with serum antibodies against the dermal side by indirect immunofluorescence microscopy on human salt-split skin.

Lau I, Goletz S, Holtsche MM, Zillikens D, Fechner K, Schmidt E.

J Am Acad Dermatol. 2019 Apr 3. pii: S0190-9622(19)30522-5. doi: 10.1016/j.jaad.2019.03.077. [Epub ahead of print] No abstract available.

PMID:
30953703
2.

Development of Rapid Extraction Method of Mycobacterium avium Subspecies paratuberculosis DNA from Bovine Stool Samples.

Hansen S, Roller M, Alslim LMA, Böhlken-Fascher S, Fechner K, Czerny CP, Abd El Wahed A.

Diagnostics (Basel). 2019 Mar 29;9(2). pii: E36. doi: 10.3390/diagnostics9020036.

3.

Anti-Homer-3 antibody associated cerebellar ataxia: A rare case report and literature review.

Xu X, Ren H, Li L, Wang J, Fechner K, Guan H.

J Neuroimmunol. 2019 May 15;330:155-158. doi: 10.1016/j.jneuroim.2019.01.002. Epub 2019 Mar 13.

PMID:
30904736
4.

Tryptophan-kynurenine profile in pediatric autoimmune hepatitis.

Lytton SD, Osiecki M, MałgorzataWoźniak, Cukrowska B, Wierzbicka A, Goliszek M, Socha P, Janczyk W, Dayanakli D, Abendroth D, Kramp S, Fechner K, Scheper T, Mahler M, Bentow C, Bogdanos D, Fuchs D, Woynarowski M.

Immunol Res. 2019 Feb;67(1):39-47. doi: 10.1007/s12026-019-9068-1.

PMID:
30666511
5.

Performance analysis of automated evaluation of antinuclear antibody indirect immunofluorescent tests in a routine setting.

van Beers JJBC, Hahn M, Fraune J, Mallet K, Krause C, Hormann W, Fechner K, Damoiseaux JGMC.

Auto Immun Highlights. 2018 Sep 21;9(1):8. doi: 10.1007/s13317-018-0108-y.

6.

A sensitive and specific assay for the serological diagnosis of antilaminin 332 mucous membrane pemphigoid.

Goletz S, Probst C, Komorowski L, Schlumberger W, Fechner K, van Beek N, Holtsche MM, Recke A, Yancey KB, Hashimoto T, Antonicelli F, Di Zenzo G, Zillikens D, Stöcker W, Schmidt E.

Br J Dermatol. 2019 Jan;180(1):149-156. doi: 10.1111/bjd.17202. Epub 2018 Nov 1.

PMID:
30216412
7.

Significance of serological markers in the disease course of ulcerative colitis in a prospective clinical cohort of patients.

Kovacs G, Sipeki N, Suga B, Tornai T, Fechner K, Norman GL, Shums Z, Antal-Szalmas P, Papp M.

PLoS One. 2018 Mar 28;13(3):e0194166. doi: 10.1371/journal.pone.0194166. eCollection 2018.

8.

MOG-IgG in primary and secondary chronic progressive multiple sclerosis: a multicenter study of 200 patients and review of the literature.

Jarius S, Ruprecht K, Stellmann JP, Huss A, Ayzenberg I, Willing A, Trebst C, Pawlitzki M, Abdelhak A, Grüter T, Leypoldt F, Haas J, Kleiter I, Tumani H, Fechner K, Reindl M, Paul F, Wildemann B.

J Neuroinflammation. 2018 Mar 19;15(1):88. doi: 10.1186/s12974-018-1108-6. Review.

9.

Loss of tolerance to gut immunity protein, glycoprotein 2 (GP2) is associated with progressive disease course in primary sclerosing cholangitis.

Tornai T, Tornai D, Sipeki N, Tornai I, Alsulaimani R, Fechner K, Roggenbuck D, Norman GL, Veres G, Par G, Par A, Szalay F, Lakatos PL, Antal-Szalmas P, Papp M.

Sci Rep. 2018 Jan 10;8(1):399. doi: 10.1038/s41598-017-18622-1.

10.

DETECTION OF MYCOBACTERIUM AVIUM SUBSPECIES PARATUBERCULOSIS IN ROCK HYRAXES ( PROCAVIA CAPENSIS) IMPORTED FROM SOUTH AFRICA.

Fechner K, Schäfer J, Münster P, Ternes K, Döring S, Völkel I, Kaup FJ, Czerny CP.

J Zoo Wildl Med. 2017 Dec;48(4):1086-1094. doi: 10.1638/1042-7260-48.4.1086.

PMID:
29297824
11.

Routine detection of serum antidesmocollin autoantibodies is only useful in patients with atypical pemphigus.

Mindorf S, Dettmann IM, Krüger S, Fuhrmann T, Rentzsch K, Karl I, Probst C, Komorowski L, Fechner K, van Beek N, Lemcke S, Sárdy M, Bangert C, Benoit S, Hashimoto T, Zillikens D, Pas HH, Jonkman MF, Stöcker W, Schmidt E; International Autoimmune Bullous Diseases Study Group.

Exp Dermatol. 2017 Dec;26(12):1267-1270. doi: 10.1111/exd.13409. Epub 2017 Oct 29.

PMID:
28815795
12.

IgLON5 antibody: Neurological accompaniments and outcomes in 20 patients.

Honorat JA, Komorowski L, Josephs KA, Fechner K, St Louis EK, Hinson SR, Lederer S, Kumar N, Gadoth A, Lennon VA, Pittock SJ, McKeon A.

Neurol Neuroimmunol Neuroinflamm. 2017 Jul 18;4(5):e385. doi: 10.1212/NXI.0000000000000385. eCollection 2017 Sep.

13.

Performance analysis of automated evaluation of Crithidia luciliae-based indirect immunofluorescence tests in a routine setting - strengths and weaknesses.

Hormann W, Hahn M, Gerlach S, Hochstrate N, Affeldt K, Giesen J, Fechner K, Damoiseaux JGMC.

Clin Chem Lab Med. 2017 Nov 27;56(1):86-93. doi: 10.1515/cclm-2017-0326.

PMID:
28672732
14.

Detection of Mycobacterium avium subsp. paratuberculosis in non-human primates.

Fechner K, Mätz-Rensing K, Lampe K, Kaup FJ, Czerny CP, Schäfer J.

J Med Primatol. 2017 Oct;46(5):211-217. doi: 10.1111/jmp.12270. Epub 2017 Apr 26.

PMID:
28444886
15.

Development of a Recombinase Polymerase Amplification Assay for Rapid Detection of the Mycobacterium avium subsp. paratuberculosis.

Hansen S, Schäfer J, Fechner K, Czerny CP, Abd El Wahed A.

PLoS One. 2016 Dec 19;11(12):e0168733. doi: 10.1371/journal.pone.0168733. eCollection 2016.

16.

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome.

Jarius S, Kleiter I, Ruprecht K, Asgari N, Pitarokoili K, Borisow N, Hümmert MW, Trebst C, Pache F, Winkelmann A, Beume LA, Ringelstein M, Stich O, Aktas O, Korporal-Kuhnke M, Schwarz A, Lukas C, Haas J, Fechner K, Buttmann M, Bellmann-Strobl J, Zimmermann H, Brandt AU, Franciotta D, Schanda K, Paul F, Reindl M, Wildemann B; in cooperation with the Neuromyelitis Optica Study Group (NEMOS).

J Neuroinflammation. 2016 Nov 1;13(1):281.

17.

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.

Jarius S, Ruprecht K, Kleiter I, Borisow N, Asgari N, Pitarokoili K, Pache F, Stich O, Beume LA, Hümmert MW, Ringelstein M, Trebst C, Winkelmann A, Schwarz A, Buttmann M, Zimmermann H, Kuchling J, Franciotta D, Capobianco M, Siebert E, Lukas C, Korporal-Kuhnke M, Haas J, Fechner K, Brandt AU, Schanda K, Aktas O, Paul F, Reindl M, Wildemann B; in cooperation with the Neuromyelitis Optica Study Group (NEMOS).

J Neuroinflammation. 2016 Sep 27;13(1):280.

18.

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.

Jarius S, Ruprecht K, Kleiter I, Borisow N, Asgari N, Pitarokoili K, Pache F, Stich O, Beume LA, Hümmert MW, Trebst C, Ringelstein M, Aktas O, Winkelmann A, Buttmann M, Schwarz A, Zimmermann H, Brandt AU, Franciotta D, Capobianco M, Kuchling J, Haas J, Korporal-Kuhnke M, Lillevang ST, Fechner K, Schanda K, Paul F, Wildemann B, Reindl M; in cooperation with the Neuromyelitis Optica Study Group (NEMOS).

J Neuroinflammation. 2016 Sep 26;13(1):279.

19.

Inositol 1,4,5-trisphosphate receptor type 1 autoantibodies in paraneoplastic and non-paraneoplastic peripheral neuropathy.

Jarius S, Ringelstein M, Haas J, Serysheva II, Komorowski L, Fechner K, Wandinger KP, Albrecht P, Hefter H, Moser A, Neuen-Jacob E, Hartung HP, Wildemann B, Aktas O.

J Neuroinflammation. 2016 Oct 24;13(1):278.

20.

Multiparametric serological testing in autoimmune encephalitis using computer-aided immunofluorescence microscopy (CAIFM).

Fraune J, Gerlach S, Rentzsch K, Teegen B, Lederer S, Affeldt K, Fechner K, Danckwardt M, Voigt J, Probst C, Komorowski L, Stöcker W.

Autoimmun Rev. 2016 Oct;15(10):937-42. doi: 10.1016/j.autrev.2016.07.024. Epub 2016 Aug 1. Review.

PMID:
27490202
21.

Primate liver tissue as an alternative substrate for endomysium antibody immunofluorescence testing in diagnostics of paediatric coeliac disease.

Wolf J, Jahnke A, Fechner K, Richter T, Laass MW, Hauer A, Stern M, de Laffolie J, Flemming G, Mothes T.

Clin Chim Acta. 2016 Sep 1;460:72-7. doi: 10.1016/j.cca.2016.06.023. Epub 2016 Jun 23.

PMID:
27346479
22.

Parkinson disease and multiple sclerosis are not associated with autoantibodies against structural proteins of the dermal-epidermal junction.

Recke A, Oei A, Hübner F, Fechner K, Graf J, Hagenah J, May C, Woitalla D, Salmen A, Zillikens D, Gold R, Schlumberger W, Schmidt E.

Br J Dermatol. 2016 Aug;175(2):407-9. doi: 10.1111/bjd.14538. Epub 2016 May 18. No abstract available.

PMID:
26972435
23.

Distribution of Mycobacterium avium subsp. paratuberculosis in a Subclinical Naturally Infected German Fleckvieh Bull.

Fechner K, Schäfer J, Wiegel C, Ludwig J, Münster P, Sharifi AR, Wemheuer W, Czerny CP.

Transbound Emerg Dis. 2017 Jun;64(3):916-928. doi: 10.1111/tbed.12459. Epub 2015 Dec 15.

PMID:
26671341
24.

Automated Evaluation of Crithidia luciliae Based Indirect Immunofluorescence Tests: A Novel Application of the EUROPattern-Suite Technology.

Gerlach S, Affeldt K, Pototzki L, Krause C, Voigt J, Fraune J, Fechner K.

J Immunol Res. 2015;2015:742402. doi: 10.1155/2015/742402. Epub 2015 Oct 25.

25.

Rediscovery of the Anti-Pancreatic Antibodies and Evaluation of their Prognostic Value in a Prospective Clinical Cohort of Crohn's Patients: The Importance of Specific Target Antigens [GP2 and CUZD1].

Papp M, Sipeki N, Tornai T, Altorjay I, Norman GL, Shums Z, Roggenbuck D, Fechner K, Stöcker W, Antal-Szalmas P, Veres G, Lakatos PL.

J Crohns Colitis. 2015 Aug;9(8):659-68. doi: 10.1093/ecco-jcc/jjv087. Epub 2015 May 12.

PMID:
25968583
26.

EUROPattern Suite technology for computer-aided immunofluorescence microscopy in autoantibody diagnostics.

Krause C, Ens K, Fechner K, Voigt J, Fraune J, Rohwäder E, Hahn M, Danckwardt M, Feirer C, Barth E, Martinetz T, Stöcker W.

Lupus. 2015 Apr;24(4-5):516-29. doi: 10.1177/0961203314559635. Review.

PMID:
25801895
27.

Diagnostic profile on the IFA 40: HEp-20-10 - an immunofluorescence test for reliable antinuclear antibody screening.

Rohwäder E, Locke M, Fraune J, Fechner K.

Expert Rev Mol Diagn. 2015 Apr;15(4):451-62. doi: 10.1586/14737159.2015.993612. Epub 2014 Dec 20.

PMID:
25530004
28.

Aquaporin-4 antibody testing: direct comparison of M1-AQP4-DNA-transfected cells with leaky scanning versus M23-AQP4-DNA-transfected cells as antigenic substrate.

Jarius S, Paul F, Fechner K, Ruprecht K, Kleiter I, Franciotta D, Ringelstein M, Pache F, Aktas O, Wildemann B.

J Neuroinflammation. 2014 Jul 29;11:129. doi: 10.1186/1742-2094-11-129.

29.

Clinical, paraclinical and serological findings in Susac syndrome: an international multicenter study.

Jarius S, Kleffner I, Dörr JM, Sastre-Garriga J, Illes Z, Eggenberger E, Chalk C, Ringelstein M, Aktas O, Montalban X, Fechner K, Stöcker W, Ringelstein EB, Paul F, Wildemann B.

J Neuroinflammation. 2014 Mar 8;11:46. doi: 10.1186/1742-2094-11-46.

30.

Differential diagnosis of membranous nephropathy with autoantibodies to phospholipase A2 receptor 1.

Schlumberger W, Hornig N, Lange S, Probst C, Komorowski L, Fechner K, Dähnrich C, Stöcker W.

Autoimmun Rev. 2014 Feb;13(2):108-13. doi: 10.1016/j.autrev.2013.09.005. Epub 2013 Sep 26.

31.

High prevalence of IgA class anti-neutrophil cytoplasmic antibodies (ANCA) is associated with increased risk of bacterial infection in patients with cirrhosis.

Papp M, Sipeki N, Vitalis Z, Tornai T, Altorjay I, Tornai I, Udvardy M, Fechner K, Jacobsen S, Teegen B, Sumegi A, Veres G, Lakatos PL, Kappelmayer J, Antal-Szalmas P.

J Hepatol. 2013 Sep;59(3):457-66. doi: 10.1016/j.jhep.2013.04.018. Epub 2013 Apr 29.

PMID:
23639483
32.

Distribution of Mycobacterium avium ssp. paratuberculosis in a German zoological garden determined by IS900 semi-nested and quantitative real-time PCR.

Münster P, Fechner K, Völkel I, von Buchholz A, Czerny CP.

Vet Microbiol. 2013 Apr 12;163(1-2):116-23. doi: 10.1016/j.vetmic.2012.12.009. Epub 2012 Dec 14.

PMID:
23298700
33.

Automated indirect immunofluorescence evaluation of antinuclear autoantibodies on HEp-2 cells.

Voigt J, Krause C, Rohwäder E, Saschenbrecker S, Hahn M, Danckwardt M, Feirer C, Ens K, Fechner K, Barth E, Martinetz T, Stöcker W.

Clin Dev Immunol. 2012;2012:651058. doi: 10.1155/2012/651058. Epub 2012 Nov 11.

34.

Serological diagnosis of autoimmune bullous skin diseases: prospective comparison of the BIOCHIP mosaic-based indirect immunofluorescence technique with the conventional multi-step single test strategy.

van Beek N, Rentzsch K, Probst C, Komorowski L, Kasperkiewicz M, Fechner K, Bloecker IM, Zillikens D, Stöcker W, Schmidt E.

Orphanet J Rare Dis. 2012 Aug 9;7:49. doi: 10.1186/1750-1172-7-49.

35.

Autoantibody detection in bullous pemphigoid: clinical evaluation of the EUROPLUS™ Dermatology Mosaic.

Damoiseaux J, van Rijsingen M, Warnemünde N, Dähnrich C, Fechner K, Tervaert JW.

J Immunol Methods. 2012 Aug 31;382(1-2):76-80. doi: 10.1016/j.jim.2012.05.007. Epub 2012 May 9.

PMID:
22580378
36.

An immunofluorescence test for phospholipase-A₂-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis.

Hoxha E, Harendza S, Zahner G, Panzer U, Steinmetz O, Fechner K, Helmchen U, Stahl RA.

Nephrol Dial Transplant. 2011 Aug;26(8):2526-32. doi: 10.1093/ndt/gfr247. Epub 2011 Jun 1.

PMID:
21633097
37.

PLA2R autoantibodies and recurrent membranous nephropathy after transplantation.

Stahl R, Hoxha E, Fechner K.

N Engl J Med. 2010 Jul 29;363(5):496-8. doi: 10.1056/NEJMc1003066. No abstract available.

PMID:
20818871
38.

Comparison of mesenchymal stem cells from bone marrow and adipose tissue for bone regeneration in a critical size defect of the sheep tibia and the influence of platelet-rich plasma.

Niemeyer P, Fechner K, Milz S, Richter W, Suedkamp NP, Mehlhorn AT, Pearce S, Kasten P.

Biomaterials. 2010 May;31(13):3572-9. doi: 10.1016/j.biomaterials.2010.01.085. Epub 2010 Feb 11.

PMID:
20153047
39.

[Novel software-based and validated evaluation method for objective quantification of bone regeneration in experimental bone defects].

Schönberger T, Kasten P, Fechner K, Südkamp NP, Pearce S, Niemeyer P.

Z Orthop Unfall. 2010 Jan;148(1):19-25. doi: 10.1055/s-0029-1186109. Epub 2009 Oct 19. German.

PMID:
20135589
40.

EUROPLUS ANCA BIOCHIP mosaic: PR3 and MPO antigen microdots improve the laboratory diagnostics of ANCA-associated vasculitis.

Damoiseaux J, Steller U, Buschtez M, Vaessen M, Rosemann A, van Paassen P, Stöcker W, Fechner K, Tervaert JW.

J Immunol Methods. 2009 Aug 31;348(1-2):67-73. doi: 10.1016/j.jim.2009.07.001. Epub 2009 Jul 14.

PMID:
19615371
41.

Ago-antagonists for G protein-coupled peptide hormone receptor by modifying the agonist's signalling domain.

Beyermann M, Heinrich N, Fechner K, Furkert J, Zhang W, Kraetke O, Bienert M, Berger H.

Adv Exp Med Biol. 2009;611:541-2. No abstract available.

PMID:
19400304
42.

Synthesis of protein mimics with nonlinear backbone topology by a combined recombinant, enzymatic, and chemical synthesis strategy.

Pritz S, Kraetke O, Klose A, Klose J, Rothemund S, Fechner K, Bienert M, Beyermann M.

Angew Chem Int Ed Engl. 2008;47(19):3642-5. doi: 10.1002/anie.200705718. No abstract available.

PMID:
18383498
43.

Achieving signalling selectivity of ligands for the corticotropin-releasing factor type 1 receptor by modifying the agonist's signalling domain.

Beyermann M, Heinrich N, Fechner K, Furkert J, Zhang W, Kraetke O, Bienert M, Berger H.

Br J Pharmacol. 2007 Jul;151(6):851-9. Epub 2007 May 29.

44.

The influence of human plasma used for in vitro dentin perfusion on microtensile bond strength of 5 self-conditioning dentin adhesives.

Gernhardt CR, Bekes K, Fechner K, Schaller HG.

Quintessence Int. 2006 Jun;37(6):429-35.

PMID:
16752698
45.

Impact of N-terminal domains for corticotropin-releasing factor (CRF) receptor-ligand interactions.

Klose J, Fechner K, Beyermann M, Krause E, Wendt N, Bienert M, Rudolph R, Rothemund S.

Biochemistry. 2005 Feb 8;44(5):1614-23.

PMID:
15683245
46.

Hexa-histidin tag position influences disulfide structure but not binding behavior of in vitro folded N-terminal domain of rat corticotropin-releasing factor receptor type 2a.

Klose J, Wendt N, Kubald S, Krause E, Fechner K, Beyermann M, Bienert M, Rudolph R, Rothemund S.

Protein Sci. 2004 Sep;13(9):2470-5. Epub 2004 Aug 4.

47.

Regulation of the coupling to different G proteins of rat corticotropin-releasing factor receptor type 1 in human embryonic kidney 293 cells.

Wietfeld D, Heinrich N, Furkert J, Fechner K, Beyermann M, Bienert M, Berger H.

J Biol Chem. 2004 Sep 10;279(37):38386-94. Epub 2004 Jul 12.

49.

Cutaneous expression of CRH and CRH-R. Is there a "skin stress response system?".

Slominski AT, Botchkarev V, Choudhry M, Fazal N, Fechner K, Furkert J, Krause E, Roloff B, Sayeed M, Wei E, Zbytek B, Zipper J, Wortsman J, Paus R.

Ann N Y Acad Sci. 1999 Oct 20;885:287-311. Review.

PMID:
10816662
50.

Corticotropin releasing hormone and related peptides can act as bioregulatory factors in human keratinocytes.

Slominski AT, Roloff B, Zbytek B, Wei ET, Fechner K, Curry J, Wortsman J.

In Vitro Cell Dev Biol Anim. 2000 Mar;36(3):211-6.

PMID:
10777063

Supplemental Content

Loading ...
Support Center